comprehensive
Previous article:
Sports medicine is finally prioritizing gender equality
Next article: UCB departs biotech trade group BIO
Next article: UCB departs biotech trade group BIO
focus
hotspot
-
Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi
2025-08-26 10:51 -
At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves
2025-08-26 10:28 -
The FDA must approve intranasal treatments for anaphylaxis
2025-08-26 10:17 -
J&J to buy cancer drug developer Ambrx Biopharma
2025-08-26 09:25 -
Susan Tousi leaves Illumina to head cancer liquid biopsy startup
2025-08-26 08:52 -
The biotech scorecard for Q1: 17 stock
2025-08-26 08:10